2026 NPPES data Specialist NPI 1760420194 M.D.
Verify on CMS →

MARY FINNEGAN, M.D.

Specialist in OMAHA, Nebraska. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
1K
Medicare Part D claims · 445 beneficiaries · Specialist avg: 1K
Generic prescribing
87%
generic claims · 13% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
91.2492/100
▲ 8 pts above national avg 83.1 · [object Object]
Industry payments
$543.88
31 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

MARY FINNEGAN, M.D. reported a CMS MIPS final score of 91.2492/100 — above the 83.1 national average — and filed 1,424 Medicare Part D claims in 2023.

91.2492/100
MIPS score · +8 vs avg
1K
Part D claims, 2023
87%
generic prescribing
$543.88
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MARY FINNEGAN, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

91 Top 37% higher than 63% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

What does the federal data show about MARY FINNEGAN, M.D.?

High performer (top quartile)

NPI registry status

Active

Issued 06/04/2006

NPI 1760420194

Primary specialty

Specialist

High-volume

69,658 US NPIs in this specialty

Medicare Part D claims

1,424 3% vs specialty avg

2023 prescription claims

Specialty avg: 1,474

MIPS final score

91.2492/100 8.149200000000008% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in Nebraska

How Specialist compares to other specialties among Nebraska providers

Nebraska providers

Specialist share within Nebraska

1. Specialist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Specialist share within Nebraska

Medicare quality performance — MIPS

MARY FINNEGAN, M.D.'s 2023 MIPS final score plotted against the Specialist national average

High performer (top quartile)
MIPS Final Score
91.2492/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Specialist) — 91.2492/100 vs national avg 83.1

0%100%National avg83%91.2%
MIPS final score (Specialist) — 91.2492/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MARY FINNEGAN, M.D. appears in the CMS NPPES registry as a Specialist provider holding M.D. credentials at 7911 W CENTER RD, OMAHA, NE, 68124, with a listed phone of (402) 390-0333. NPI 1760420194 was issued on 06/04/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what FINNEGAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,424 prescription claims written by this provider, covering 445 Medicare beneficiaries and totaling roughly $643K in drug spend, split 13% brand-name and 87% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 91.2492/100 for the 2023 performance year (Quality 83.3305, Cost 100), compared with the national average of 83.1.

Specialist is a high-volume specialty nationwide, with 69,658 enrolled providers across 55 states and an average of 1,474 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

7911 W CENTER RD
OMAHA, NE 68124

Provider Details

NPI 1760420194
Specialty Specialist
Credentials M.D.
Gender Female
NPI Issued 06/04/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

91.2492
Final Score
Avg: 83.1
83.3305
Quality
100
Cost
85
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where MARY FINNEGAN, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

BRADDOCK FINNEGAN HELGET DERMATOLOGY, P.C
OMAHA, NE

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MARY FINNEGAN, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$544

Largest payer

ABBVIE INC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Typical

MARY FINNEGAN, M.D. — brand share 13.0%
Specialty average (est.)

13% brand-name claims vs 87% generic, on 1,424 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,424
Total Claims
$643K
Total Drug Cost
445
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,810
Total Day Supply
47,643
Brand vs Generic
13% brand / 87% generic
Brand Drug Cost
$598K
Generic Drug Cost
$45K
Antibiotic Claims
113

Patient Demographics

Average Patient Age
74.0 years
Avg HCC Risk Score
1.10
Gender Split
76% female / 24% male
Age Distribution
<65: 19, 65-74: 225, 75-84: 150, 85+: 51

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What MARY FINNEGAN, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Minoxidil
188
Doxycycline Hyclate
134
Triamcinolone Acetonide
101
Clobetasol Propionate
83
Betamethasone Valerate
71
Hydrocortisone
66
Fluorouracil
63
Finasteride
60
Methotrexate
Methotrexate Sodium
60
Metronidazole
55

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Specialist Overview

How MARY FINNEGAN, M.D. fits within the Specialist landscape nationally.

69,658
Specialist Providers in US
55
States with Specialist
1,474
Avg Claims per Provider

MARY FINNEGAN, M.D.'s 1,424 claims are below the specialty average of 1,474.

Nearby Specialist Providers in Nebraska

Other clinicians with the same primary specialty enrolled in Nebraska, drawn from the same CMS NPPES roster as FINNEGAN.

Compare Specialist nationally: see state-by-state distribution →

Frequently Asked Questions

What is MARY FINNEGAN, M.D.'s specialty?
MARY FINNEGAN, M.D. specializes in Specialist and practices in OMAHA, Nebraska. Credentials: M.D..
How much does MARY FINNEGAN, M.D. prescribe under Medicare Part D?
In 2023, MARY FINNEGAN, M.D. wrote 1,424 Medicare Part D claims totaling $643K in drug costs for 445 beneficiaries.
What is MARY FINNEGAN, M.D.'s Medicare quality score?
MARY FINNEGAN, M.D. has a CMS MIPS Final Score of 91.2492/100 (Quality: 83.3305, Cost: 100). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is MARY FINNEGAN, M.D. located?
MARY FINNEGAN, M.D. is located at 7911 W CENTER RD, OMAHA, NE, 68124. Phone: (402) 390-0333.
What is MARY FINNEGAN, M.D.'s NPI number?
MARY FINNEGAN, M.D.'s National Provider Identifier (NPI) is 1760420194, issued on 06/04/2006.
Does MARY FINNEGAN, M.D. prescribe more brand-name or generic drugs?
MARY FINNEGAN, M.D.'s prescribing is 13% brand-name and 87% generic drugs by claim count, with $598K in brand drug costs.
How many Specialist providers are there in the US?
There are 69,658 Specialist providers across 55 states in the US. The average Specialist provider writes 1,474 Medicare Part D claims per year.
What drugs does MARY FINNEGAN, M.D. prescribe most often?
Based on 2023 Medicare Part D data, MARY FINNEGAN, M.D.'s most frequently prescribed drugs include Minoxidil, Doxycycline Hyclate, Triamcinolone Acetonide. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MARY FINNEGAN, M.D. accept Medicare?
MARY FINNEGAN, M.D. appears in CMS Medicare data with 1,424 Part D claims and 445 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MARY FINNEGAN, M.D.'s credentials?
MARY FINNEGAN, M.D.'s NPI is 1760420194 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology